گروه دارویی برکت
برکت | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,070 1.81
Close Price: 5,050
Income Statement
AGM
Interim
2026/07/02 Fiscal Year 2026/03/2012 Month | 2025/06/02 Fiscal Year 2025/03/2012 Month | 2024/07/03 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | - | 1.074 Trillion | 2.93 Trillion | |
Total Revenues | 2.68 Trillion | 1.074 Trillion | 2.93 Trillion | |
Gross Profit | 2.68 Trillion | 1.074 Trillion | 2.93 Trillion | |
General & Administrative Expenses | 808.38 Billion | 661.706 Billion | 506.752 Billion | |
Operating Profit (Loss) | 1.872 Trillion | 412.411 Billion | 2.423 Trillion | |
Profit Before Tax | 1.32 Trillion | 228.418 Billion | 6.739 Trillion | |
Net Profit (Loss) After Tax | 1.32 Trillion | 228.418 Billion | 6.739 Trillion | |
Retained Earnings at Beginning of Period | 3.334 Trillion | 5.526 Trillion | 7.677 Trillion | |
Approved Dividends — Prior Year AGM | - | -1.821 Trillion | -3.89 Trillion | |
Transfer from Other Equity Items | -446.185 Billion | -427.53 Billion | -59.274 Billion | |
Allocable Profit | 4.207 Trillion | 3.506 Trillion | 10.466 Trillion | |
Legal Reserve | - | 2.957 Billion | 94.652 Billion | |
Other Reserves | 65.978 Billion | 169.286 Billion | 4.845 Trillion | |
Approved Dividends — Current Year | 329.46 Billion | - | 1.821 Trillion | |
Retained Earnings at End of Period | 3.812 Trillion | 3.334 Trillion | 3.705 Trillion | |
درآمد حاصل از سپرده های بانکی و صندوق های سرمایه گذاری | 5.324 Billion | - | - | |
درآمد سود سهام | 2.061 Trillion | - | - | |
سایر درآمدها | 613.862 Billion | - | - |